Pete Gardner is a dedicated Research Lead at Wellcome Trust, where he spearheads the Antibodies & Immunity team within the Infectious Disease programme. With a profound passion for developing new medicines that address global health challenges, Pete is committed to harnessing cutting-edge science and innovation...
Pete Gardner is a dedicated Research Lead at Wellcome Trust, where he spearheads the Antibodies & Immunity team within the Infectious Disease programme. With a profound passion for developing new medicines that address global health challenges, Pete is committed to harnessing cutting-edge science and innovation to combat infectious diseases. His current role involves leading the investment strategy and overseeing the delivery of Wellcome’s antibody portfolio, which plays a crucial role in advancing research and development for vaccines against diseases such as cholera, salmonella, and tuberculosis (TB).
Under Pete's leadership, the team is actively engaged in pioneering vaccine research and discovery, particularly focusing on TB vaccine development, which remains a significant global health challenge. He also plays a vital role in supporting Wellcome’s Infectious Disease Prevention initiatives, including the exploration of controlled human infection models (CHIMs) and innovative vaccine strategies. By fostering strategic partnerships, Pete ensures that Wellcome maximizes the value of its investments in product development, facilitating collaborations that enhance the efficacy and reach of antibody-based therapies.
With a robust background in biochemistry, immunology, and laboratory techniques such as PCR and immunohistochemistry, Pete's expertise extends beyond strategic oversight. He is adept at navigating the complexities of vaccine R&D, leveraging his skills to drive impactful projects that align with Wellcome's mission to improve global health outcomes. His work not only contributes to the scientific community but also aims to deliver tangible benefits to populations at risk from infectious diseases, underscoring his commitment to making a meaningful difference in global health.
